Helix BioPharma Announces the Appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its Board of Directors

19-Aug-2009 - Canada

Helix BioPharma Corp. announced the appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its board of directors. Professor Roszkowski-Sliz is replacing Professor Slawomir Majewski, who has stepped down from the board to assume the advisory role of European medical director for Helix.

Professor Roszkowski-Sliz is an expert in the field of lung disease and lung cancers, and is a director at the National Tuberculosis and Lung Diseases Research Institute inWarsawwhere he is also head of the clinical department. In addition, Professor Roszkowski-Sliz consults on lung diseases issues for the Polish Ministry of Health. He received his M.D. from the Medical Academy inWarsawand his Ph.D. from the Postgraduate Medical Center inWarsaw. He is an accomplished researcher with over 230 published papers.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances